𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial

✍ Scribed by Ryuji Kaji; Yuka Osako; Kazuaki Suyama; Toshio Maeda; Yasuyuki Uechi; Masaru Iwasaki

Publisher
Springer
Year
2010
Tongue
English
Weight
255 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Botulinum toxin type A for drooling in P
Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study
✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
✍ Dr. J. Jankovic; K. Schwartz; W. Clemence; A. Aswad; J. Mordaunt πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 585 KB

## Abstract Twenty‐five patients with hand tremor of 2 + (moderate) to 4 + (severe) on the tremor severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (Allergan, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If p